ClinConnect ClinConnect Logo
Search / Trial NCT00687024

Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia

Launched by THE HOSPITAL FOR SICK CHILDREN · May 26, 2008

Trial Information

Current as of May 27, 2025

Completed

Keywords

Epilepsy Magnetic Resonance Imaging Magnetoencephalography

ClinConnect Summary

Focal cortical dysplasia (FCD) is a highly epileptogenic form of malformation of cortical development that may require surgical resection for epilepsy control. With abnormal development and organization of neurons within the cortex, the white matter projecting from the abnormal cortex is likely to be abnormal as well. The abnormality in the white matter involves not only the subcortical white matter, but also the long tracts in the deep white matter associated with the dysplastic cortex. Histologically, the subcortical white matter adjacent to the dysplastic cortex has been found to be abno...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children with intractable epilepsy with suspected FCD for MRI \& MEG
  • Exclusion Criteria:
  • Children with contraindications to MRI such as those with pacemaker

About The Hospital For Sick Children

The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Charles Raybaud, M.D.

Principal Investigator

The Hospital for Sick Children

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials